Westbourne Investment Advisors Inc. Sells 35 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Westbourne Investment Advisors Inc. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,296 shares of the healthcare conglomerate’s stock after selling 35 shares during the period. Westbourne Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $1,735,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Moneta Group Investment Advisors LLC increased its position in shares of UnitedHealth Group by 100,076.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after acquiring an additional 11,812,017 shares during the last quarter. Norges Bank bought a new stake in UnitedHealth Group in the 4th quarter valued at about $5,210,004,000. Arrowstreet Capital Limited Partnership increased its stake in UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares during the period. Barclays PLC raised its position in shares of UnitedHealth Group by 143.4% in the 2nd quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock valued at $1,679,401,000 after buying an additional 2,058,829 shares in the last quarter. Finally, Morgan Stanley boosted its stake in UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after buying an additional 1,893,192 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Down 0.1 %

Shares of NYSE:UNH traded down $0.56 on Thursday, reaching $492.54. 1,295,798 shares of the company traded hands, compared to its average volume of 4,055,827. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The business’s 50-day simple moving average is $503.73 and its 200 day simple moving average is $518.79. The stock has a market capitalization of $454.09 billion, a P/E ratio of 20.64, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. During the same quarter in the prior year, the company posted $5.34 EPS. The firm’s revenue for the quarter was up 14.1% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 31.54%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on UNH shares. Oppenheimer reissued an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Truist Financial reaffirmed a “buy” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Thursday, November 30th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Royal Bank of Canada reiterated an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 29th. Finally, Stephens restated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $579.33.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.